Daoudi Chaimae, Haloui Anass, Akouh Nada, Nassira Karich, Bennani Amal
Department of Pathology, Mohammed VI University Hospital, Faculty of Medicine, Mohammed First University, Oujda, MAR.
Cureus. 2025 Feb 24;17(2):e79599. doi: 10.7759/cureus.79599. eCollection 2025 Feb.
Placental site trophoblastic tumor (PSTT) is a rare neoplasm originating from intermediate trophoblastic cells at the site of placental implantation. Its diagnosis poses significant challenges, particularly in distinguishing it from other gestational trophoblastic tumors, such as epithelioid trophoblastic tumors, choriocarcinoma, and placental site nodules, as well as the benign exaggerated placental site. We present a case of a 29-year-old woman with persistent gestational trophoblastic disease following a complete hydatidiform mole. A detailed review of the differential diagnoses is provided in tables to aid in the diagnostic process, allowing for a clearer comparison and better understanding of these conditions. This report highlights the importance of accurately identifying PSTT by eliminating potential differential diagnoses through careful pathological and clinical evaluation. We aim to assist pathologists and clinicians in recognizing this rare condition to ensure timely and appropriate management.
胎盘部位滋养细胞肿瘤(PSTT)是一种罕见的肿瘤,起源于胎盘着床部位的中间型滋养细胞。其诊断面临重大挑战,尤其是在将其与其他妊娠滋养细胞肿瘤区分开来时,如上皮样滋养细胞肿瘤、绒毛膜癌、胎盘部位结节以及良性胎盘部位超常反应。我们报告一例29岁女性,在完全性葡萄胎后发生持续性妊娠滋养细胞疾病。表格中提供了鉴别诊断的详细回顾,以辅助诊断过程,便于更清晰地比较和更好地理解这些情况。本报告强调了通过仔细的病理和临床评估排除潜在鉴别诊断来准确识别PSTT的重要性。我们旨在协助病理学家和临床医生认识这种罕见疾病,以确保及时和恰当的管理。